Nachrichten»VoluMetrix Wins People's Choice Award at American College of Cardiology NIH-NHLBI Company Showcase Push Mitteilungen ACCESS Newswire 10.04.2025 15:02 Uhr 238 Leser Artikel bewerten: (1) ...

American College of Cardiology ACC.25 Innovation Pitch Challenge People's Choice Winner The prestigious event, hosted on March 29 in the exhibit hall's Future Hub, featured presentations from four ...

"My current NIH research contracts are worth $15.9 million, of which $5.9 million still needs to be spent to finish our research," Charlton said.

The Phase 1 study (NCT05904093) is sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), and will be conducted at a single site in ...

Rigel Pharmaceuticals, Inc. has announced the enrolment of the first patient in a Phase I clinical trial evaluating fostamatinib, the company’s oral spleen tyrosine kinase (SYK) inhibitor, for ...

"We are excited to support another important study conducted by the NIH/NHLBI for fostamatinib, as they investigate SYK inhibition and its potential to benefit patients with sickle cell disease, a ...

Los Angeles, California, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is proud to announce the receipt of a $2 million grant from ...

Now this grant from NIH/NHLBI will allow us to test AWARE in a large number of individuals, a broad age range and several different airway diseases such as asthma, COPD, cystic fibrosis and others.

Supported by NIH/NHLBI T32 “Transdisciplinary Training in Sleep and Circadian Rhythms”, NIH/NINDS R25 "Multi-Institutional Summer Undergraduate Research Program to Promote Sleep and Circadian Research ...